Cargando…
Paediatric Formulation: Design and Development
The development of medicines designed for children can be challenging since this distinct patient population requires specific needs. A formulation designed for paediatric patients must consider the following aspects: patient population variability; dose flexibility; route of administration; patient...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583834/ https://www.ncbi.nlm.nih.gov/pubmed/32992469 http://dx.doi.org/10.3390/ijms21197118 |
_version_ | 1783599467926126592 |
---|---|
author | Lopalco, Antonio Denora, Nunzio |
author_facet | Lopalco, Antonio Denora, Nunzio |
author_sort | Lopalco, Antonio |
collection | PubMed |
description | The development of medicines designed for children can be challenging since this distinct patient population requires specific needs. A formulation designed for paediatric patients must consider the following aspects: patient population variability; dose flexibility; route of administration; patient compliance; drug and excipient tolerability. The purpose of this Special Issue entitled “Paediatric Formulation: Design and Development” is to provide an update on both state-of-the-art methodology and operational challenges in the design and development of paediatric formulations. It aims at re-evaluating what is needed for more progress in the design and development of age-appropriate treatments for paediatric diseases, focusing on: formulation development; drug delivery design; efficacy, safety, and tolerability of drugs and excipients. This editorial, briefly, summarizes the objects of nine original research and review papers published in this Special Issue. |
format | Online Article Text |
id | pubmed-7583834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75838342020-10-28 Paediatric Formulation: Design and Development Lopalco, Antonio Denora, Nunzio Int J Mol Sci Editorial The development of medicines designed for children can be challenging since this distinct patient population requires specific needs. A formulation designed for paediatric patients must consider the following aspects: patient population variability; dose flexibility; route of administration; patient compliance; drug and excipient tolerability. The purpose of this Special Issue entitled “Paediatric Formulation: Design and Development” is to provide an update on both state-of-the-art methodology and operational challenges in the design and development of paediatric formulations. It aims at re-evaluating what is needed for more progress in the design and development of age-appropriate treatments for paediatric diseases, focusing on: formulation development; drug delivery design; efficacy, safety, and tolerability of drugs and excipients. This editorial, briefly, summarizes the objects of nine original research and review papers published in this Special Issue. MDPI 2020-09-27 /pmc/articles/PMC7583834/ /pubmed/32992469 http://dx.doi.org/10.3390/ijms21197118 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Editorial Lopalco, Antonio Denora, Nunzio Paediatric Formulation: Design and Development |
title | Paediatric Formulation: Design and Development |
title_full | Paediatric Formulation: Design and Development |
title_fullStr | Paediatric Formulation: Design and Development |
title_full_unstemmed | Paediatric Formulation: Design and Development |
title_short | Paediatric Formulation: Design and Development |
title_sort | paediatric formulation: design and development |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583834/ https://www.ncbi.nlm.nih.gov/pubmed/32992469 http://dx.doi.org/10.3390/ijms21197118 |
work_keys_str_mv | AT lopalcoantonio paediatricformulationdesignanddevelopment AT denoranunzio paediatricformulationdesignanddevelopment |